On April 9th, Lídia Linck, director of Biotecno, made an institutional visit to the facilities of the Heart Institute (Incor) in São Paulo. Recognized as the leading cardiology and cardiovascular surgery center in Latin America, Incor is a benchmark for clinical excellence, innovation, and research in the health field.
During the visit, the head of the Cardiovascular Surgery Sector at Incor, Samuel Padovani Steffen, and biomedical scientist Carlos Eduardo da Silva Imberg, a specialist in multiple organ procurement for transplantation, highlighted the importance of the Taura device in the homogenization and proper preservation of tissues. According to Dr. Samuel Steffen, Taura has established itself as a viable and technologically advanced alternative, with the advantage of being developed by a Brazilian company, surpassing imported devices, which are disposable.
The Taura device, recently launched by Biotecno in the Brazilian market, is already integrated into the transplant procedures performed by the institution. Its adoption reinforces Incor's commitment to incorporating innovative solutions that contribute to safety and efficiency in organ preservation and transportation processes.
